SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001410578-23-001824
Filing Date
2023-08-14
Accepted
2023-08-14 06:50:31
Documents
56
Period of Report
2023-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q lptx-20230630x10q.htm   iXBRL 10-Q 1518540
2 EX-31.1 lptx-20230630xex31d1.htm EX-31.1 11004
3 EX-32.1 lptx-20230630xex32d1.htm EX-32.1 6815
  Complete submission text file 0001410578-23-001824.txt   5968476

Data Files

Seq Description Document Type Size
4 EX-101.SCH lptx-20230630.xsd EX-101.SCH 41403
5 EX-101.CAL lptx-20230630_cal.xml EX-101.CAL 34138
6 EX-101.DEF lptx-20230630_def.xml EX-101.DEF 161191
7 EX-101.LAB lptx-20230630_lab.xml EX-101.LAB 392945
8 EX-101.PRE lptx-20230630_pre.xml EX-101.PRE 280476
50 EXTRACTED XBRL INSTANCE DOCUMENT lptx-20230630x10q_htm.xml XML 977558
Mailing Address 47 THORNDIKE STREET SUITE B1-1 CAMBRIDGE MA 02142
Business Address 47 THORNDIKE STREET SUITE B1-1 CAMBRIDGE MA 02142 617 252 4343
LEAP THERAPEUTICS, INC. (Filer) CIK: 0001509745 (see all company filings)

IRS No.: 274412575 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37990 | Film No.: 231166141
SIC: 2834 Pharmaceutical Preparations